UPDATED IRON DEFICIENCY ANEMIA PATHWAY

The Calgary Zone’s iron deficiency anemia (IDA) pathway has been updated to reflect current evidence and provide additional guidance for clinicians managing patients with anemia.

Updates include an approach to new and chronic normocytic anemia, expanded recommendations for iron therapy and support for identifying underlying causes when they are not clinically evident. The pathway also includes details and comparisons of oral iron preparations, as well as guidance on dosing.